Provided by Tiger Trade Technology Pte. Ltd.

NRX Pharmaceuticals Inc.

3.49
+0.06001.75%
Post-market: 3.48-0.0100-0.29%19:57 EDT
Volume:487.59K
Turnover:1.67M
Market Cap:151.10M
PE:-4.50
High:3.50
Open:3.43
Low:3.39
Close:3.43
52wk High:5.06
52wk Low:1.62
Shares:43.30M
Float Shares:36.46M
Volume Ratio:1.12
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7754
EPS(LYR):-1.3374
ROE:-682.61%
ROA:-63.99%
PB:-888.84
PE(LYR):-2.61

Loading ...

NRX Pharmaceuticals (Nasdaq:Nrxp) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRX’s Preservative-Free Ketamine Application

THOMSON REUTERS
·
Mar 17

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 17

NRx Pharmaceuticals confirms path to NDA following Type C meeting

TIPRANKS
·
Mar 16

FDA agrees to review NRX-100 NDA using clinical trials and real-world evidence

Reuters
·
Mar 16

NRX Pharmaceuticals Inc - to Submit Nda for NRX-100 by June 2026

THOMSON REUTERS
·
Mar 16

NRX Pharmaceuticals (Nasdaq:Nrxp) Confirms Path to New Drug Application With Real World Data and Broader Proposed Indication for NRX-100 (Ketamine) Following Type C FDA Meeting

THOMSON REUTERS
·
Mar 16

NRX Pharmaceuticals Inc: No Additional Clinical Trials Were Requested

THOMSON REUTERS
·
Mar 16

NRX Pharmaceuticals Inc - FDA Confirms No Additional Nonclinical Data or Bridging Studies Required for NRX-100

THOMSON REUTERS
·
Mar 16

NRX Pharmaceuticals Inc expected to post breakeven results a share - Earnings Preview

Reuters
·
Mar 13

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 10

Hope Therapeutics, an NRX Subsidiary (Nasdaq:Nrxp) Announces Opening of Palm Beach, Fl Clinic Offering One Day Treatment for Depression and Ptsd

THOMSON REUTERS
·
Mar 09

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

GlobeNewswire
·
Mar 09

NRX Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 04

NRx Pharmaceuticals price target raised to $45 from $40 at H.C. Wainwright

TIPRANKS
·
Mar 03

NRx Pharmaceuticals Names Prof. Joshua Brown Chief Medical Innovation Officer

Reuters
·
Mar 02

NRX Pharmaceuticals (Nasdaq: Nrxp) Appoints Prof. Joshua Brown Md, Phd, as Chief Medical Innovation Officer

THOMSON REUTERS
·
Mar 02